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KYRTl, A DISARMED VERSION OF A 
HIGHLY TUMORIGENIC AGROBA C TERI UM 
T UMEFACIENS STRAIN IDENTIFIED AS 
CHRY5 
TECHNICAL FIELD 
The invention relates to novel disarmed Agrobacterium 
tumefaciens vectors useful for the transformation of plants. 
More particularly, the invention relates to disarmed A. 
tumefaciens vectors, methods of their use and transgenic 
plants, particularly dicotyledonous transgenic plants, created 
thereby. Yet more particularly, the invention relates to dis 
armed A. tumefaciens strain designated KYRT1 and meth 
ods of its use and transgenic soybean plants made thereby. 
BACKGROUND ART 
Soybean is an agronomically important crop. Despite this 
importance, hoWever, there is only limited breeding poten 
tial in the United States due to a small germplasm base. As 
a result, tremendous efforts have been expended in devel 
oping techniques to modify soybean characteristics through 
the use of genetic engineering. Such modi?cations offer the 
possibility of developing plant lines that have speci?c, 
tailor-made bene?cial traits, such as herbicide resistance, 
drought resistance, heat resistance, disease resistance, seed 
quality improvement, and the like, in Ways not possible 
using traditional breeding techniques. Due to the successes 
of Agrobacterium tumefaciens-mediated gene transfer in 
other plant species, much effort has been placed on devel 
oping such a system for the genetic modi?cation of soybean. 
To date, hoWever, these efforts have met With only limited 
success, With generally loW transformation ef?ciencies on 
most soybean cultivars. 
Agrobacterium tumefaciens is a gram-negative soil bac 
teria that causes the croWn gall disease in plants by infecting 
cells through Wound sites. A. tumefaciens infects by inject 
ing into the cell a strand of DNA (termed T-DNA) derived 
from the large tumor-inducing (Ti) plasmid (van Larebeke et 
al., Nature 255: 742—743, 1975). The T-DNA then integrates 
into a chromosomal location in the plant and produces 
enZymes that synthesiZe hormones Which cause the croWn 
gall symptoms (Chilton et al., Cell 11: 263—271, 1977). The 
genes encoding these enZymes, and the eukaryotic regula 
tory control elements associated thereWith, are located on 
the T-DNA. In addition, the integrated T-DNA also encodes 
products that direct the synthesis of compounds knoWn as 
opines, Which are amino acid and sugar derivatives, Which 
varies depending upon the A. tumefaciens strain. 
Mobilization of the T-DNA requires that the products of 
genes located elseWhere on the Ti plasmid, called collec 
tively the vir genes, Which are activated by certain elicitors 
from the Wounded plant cells in trans to synthesiZe and 
transfer a single-stranded copy of the T-DNA (the T-strand) 
to the plant cell (Zambryski,Ann. Rev. Plant. Physiol. Plant 
Mol. Biol. 43: 465—490, 1992; Zupan and Zambryski, Plant 
Physiol. 107: 1041—1047, 1995). The T-DNA sequence on 
the Ti plasmid is ?anked by short 24-bp direct repeats 
(Yadav et al., Proc. Natl. Acad. Sci. (USA), 1982), Which are 
required for the recognition of the T-DNA (Wang et al., Cell 
38: 455—462, 1984). Sequences immediately surrounding 
these borders appear to be involved in the polarity of 
T-strand synthesis, Which initiates at the right border (Wang 
et al., Mol. Gen. Genet. 210: 338—346, 1987). 
The discovery of the mechanism by Which A. tumefaciens 
infects plant cells, i.e. by DNA transfer, led to the realiZation 













for transferring agronomically useful genes to plants. 
Recently it has been demonstrated that foreign DNA, 
?anked by T-DNA border sequences, can be transferred into 
plant cells using A. tumefaciens as the vector (Hernalsteens 
et al., Nature 287:654—65 6, 1980). Furthermore, inactivation 
or removal of the native T-DNA genes involved in hormone 
synthesis Would render the A. tumefaciens incapable of 
producing the croWn gall disease symptoms. This process of 
inactivating or removing genes responsible for disease 
symptoms is termed “disarming.” 
The ?rst methods of A. tumefaciens engineering involved 
the simultaneous disarming and introduction of the desired 
gene, since the introduced gene directly replaced the genes 
in the T-DNA. By a method termed “homogenotiZation” 
(MatZke and Chilton, J. Mol. Appl. Genet. 1: 39—49, 1981), 
the native T-DNA of the Ti plasmid Was replaced With a 
desired gene for transformation. Homologous recombina 
tion occurred betWeen the T-DNA of the Ti plasmid and an 
intermediate construct in a broad host range plasmid, con 
taining the desired gene and a selectable marker (e.g., drug 
resistance) ?anked by T-DNA sequences. The recombination 
event Was forced by a subsequent introduction of a second 
broad host range plasmid incompatible to the intermediate 
construct, and selecting for drug-resistance encoded by the 
selectable marker gene of the introduced T-DNA in the 
desired construct, and the drug-resistance gene on the 
incompatible plasmid. 
Another strategy developed for engineering A. tumefa 
ciens involved cloning the desired gene into a cointegrative 
intermediate vector, Which contained a single region of 
T-DNA homology and a single border sequence. In this 
system, the sequences are recombined by a single-crossover 
event (Horsch et al., Science 227: 1229—1231, 1985), Which 
results in the entire vector, including the gene of interest, 
being integrated. Cointegrative systems pair in regions of 
homology betWeen the T-DNA region of the Ti plasmid and 
the DNA sequence on the introduced integrative vector. 
One example of a useful cointegrative plasmid is 
pGV3850, a Ti plasmid from a nopaline strain (C58), from 
Which the entire T-DNA region betWeen the borders Was 
replaced With pBR322, thus offering a recombination site for 
any gene construct containing pBR322 homology 
(Zambryski et al., EMBO J. 2(12): 2143—2150, 1983). 
Upon the discovery that T-DNA does not have to be on the 
same plasmid as the vir genes (de Framond et al., Bi0/ 
Technol. 1: 262—269, 1983; Hoekema et al., Nature 303: 
179—180, 1983), the binary vector Was developed. A binary 
vector is maintained in the A. tumefaciens separate from the 
Ti plasmid, and contains the gene of interest and a selectable 
marker gene betWeen T-DNA border sequences. These vec 
tors offer a great degree of ?exibility, since they do not 
require a speci?cally engineered Ti plasmid With a homolo 
gous recombination site. For that reason, any disarmed A. 
tumefaciens strain can be used to transfer genes for any 
binary vector. OWing to their versatility, binary vectors are 
currently the preferred intermediate vectors for cloning 
genes destined for A. tumefaciens-mediated transfer into 
plants. HoWever, any A. tumefaciens strain to be used With 
binary vectors must have its oWn Ti plasmid disarmed, 
especially if the target plant species is inef?ciently trans 
formed viaA. tumefaciens. OtherWise, the desired gene from 
the binary vector Will be co-transformed With the oncogenic 
phytohormone genes from the native T-DNA of the bacteria, 
thereby reducing transformation ef?ciency of the desired 
gene and also producing the tumorigenic disease symptoms 
in many of the target cells and thereby preventing the 
differentiation of these cells into normal plants. 
5,929,306 
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Disarming Wild-type A. tumefaciens strains for general 
use With binary vectors has involved, in some cases, a form 
of homogenotiZation. An intermediate construct containing 
a marker gene ?anked by Ti plasmid sequences that are 
homologous to regions that lie outside the T-DNA, is intro 
duced into the Wild-type A. tumefaciens by bacterial conju 
gation (Hood et al., J. Bacteriol. 168(3): 1291—1301, 1986; 
Hood et al., Transgenic Res. 2: 208—218, 1993). Whereas 
disarmed A. tumefaciens strains typically have their entire 
T-DNA sequences removed, it has also been demonstrated 
that T-DNA mobiliZation can be inactivated by removal of 
the right border sequence: reports from Work With nopaline 
type strains of A. tumefaciens shoW that the right border of 
T-DNA is necessary for gene transfer, Whereas the left 
border is not. (Joos et al., Cell 32: 1057—1067, 1983; Peralto 
and Ream, Proc. Natl. Acad. Sci. (USA), 1985; ShaW et al., 
NucleicAcids Res., 12: 6031—6041, 1984; Wang et al., Mol. 
Gen. Genet. 210: 338—346, 1984). 
A. tumefaciens has a diverse dicot host range, and addi 
tionally some monocot families (De Cleene and De Layk, 
Bot. Rev. 42 (4): 389—466, 1976). There are several different 
strains of A. tumefaciens, each classi?ed into octopine-type, 
nopaline-type, and L,L-succinamopine-type, named after 
type of opine synthesiZed in the plant cells they infect. These 
strains have comparable, although not identical, host ranges 
and disarmed versions of many types of A. tumefaciens have 
been used successfully for gene transfer into a variety of 
plant species. (van Wordragen et al., Plant Mol. Biol. Rep. 
10: 12—36, 1992; Hood et al., Transgenic Res. 2: 208—218, 
1993). Although its most sensitive hosts are members of the 
dicot family Solanaceae, A. tumefaciens, as mentioned 
above, has also been demonstrated to infect some monocots 
as Well (Smith and Hood, Crop Sci. 35(2): 301—309, 1995). 
HoWever, soybean (Glycine max L. Merr.) has proven to 
be very di?icult to transform With A. tumefaciens, at least in 
part because it is refractory to infection by Wild-type A. 
tumefaciens. Comparative studies With a number of soybean 
cultivars and A. tumefaciens strains suggest that soybean 
susceptibility to A. tumefaciens is limited, and is both 
cultivar- and bacterial strain dependent (Bush and Pueppke, 
Appl. Environ. Microbiol. 57(9): 2468—2472, 1991; Byrne et 
al., Plant Cell Tiss. Org. Cult. 8: 3—15, 1987; Hood et al., 
Plant Physiol. 83:529—534, 1987). The problems With soy 
bean recalcitrance to A. tumefaciens are further complicated 
by the difficulty of Working With soybean in tissue culture. 
Progress in A. tumefaciens-mediated gene transfer in 
soybean is limited by tWo major factors: (1) development of 
a soybean tissue culture system that e?iciently regenerates 
plants from a single-cell origin (Cheng et al., Plant Sci. Let. 
19: 91—99, 1980; Wright et al., Plant Cell Rep. 5: 150—154, 
1986), and (2) further understanding of the mechanism for 
A. tumefaciens-mediated gene transfer, i.e., the fact that 
certain chemical elicitors applied externally (e.g., 
acetosyringone) can stimulate vir gene activation and 
T-DNA transfer into cells of non-host plants such as soybean 
(OWens and Smigocki, Plant Physiol. 88: 570—573, 1988; 
Stachel et al., Nature 318: 624—629, 1985). 
One system for soybean A. tumefaciens-mediated gene 
transfer has noW been established, and is in Wide use 
(ToWnsend, International Patent Application WO 94/02620, 
1994; Hinchee and Conner-Ward, US. Pat. No. 5,416,011, 
1995). Despite these advances to date, hoWever, A. 
tumefaciens-mediated gene transfer into soybean remains 
ine?icient and labor-intensive, and methods for improving 
that efficiency are continually being sought. 
As mentioned earlier, some A. tumefaciens strains infect 













supervirulent, broad host-range, L,L-succinamopine-type A. 
tumefaciens strain that shoWs high virulence on soybean. 
Strain A281 has a nopaline-type C58 chromosomal 
background, containing the L,L-succinamopine-type Ti 
plasmid, pTiBo542, and out-performs its chromosomal and 
Ti plasmid progenitors on soybean (Hood et al., Plant 
Physiol. 83: 529—534, 1987). Disarming this strain has 
produced EHA101 and EHA105, strains noW Widely used in 
conjunction With soybean transformation (Hood et al., J. 
Bacteriol. 168(3): 1283—1290, 1986; Hood et al., Plant 
Physiol. 83: 529—534, 1987). 
Recently, Chry5, another L,L-succinamopine-type strain 
of A. tumefaciens recovered from chrysanthemum, has been 
found to have a broad host range, and is also highly virulent 
on soybean (Bush and Pueppke, Appl. Environm. M icrobiol. 
57(9): 2468—2472, 1991). The Ti plasmid of this strain, 
designated pTiChry5, is comparable in arrangement and 
homology to pTiBo542 in supervirulent strain A281. The 
Chry5 strain also possesses a cryptic plasmid, the purpose of 
Which is unclear. Based on stem inoculation assays, Chry5 
rivals A281 (Hood et al., Plant Physiol. 83: 529—534, 1987) 
for tumorigenicity on soybean. 
The sequences of pTiChry5 have been subcloned as 
partial EcoRI fragments into a cosmid library in pLAFR1 
(Friedman et al., Gene 18: 289—296, 1982), and mapped for 
EcoRI and BamHI sites and for vir, inc, L,L-succinamopine 
utiliZation, and the T-DNA regions, based on homology to 
pTiBo542 of A281. Observations from complementation 
analysis suggest key cis-acting elements in pTiChry5 near 
the T-DNA right border as being involved With superviru 
lence. HoWever, studies involving transferring pTiChry5 
into other A. tumefaciens strains suggest that there may also 
be chromosomal involvement in the hypervirulence of 
Chry5 observed With soybean (Kovacs and Pueppke, Mol. 
Gen. Genet. 242: 327—336, 1994). 
US. Pat. No. 5,416,011 discloses a method for the trans 
formation of soybean, With a disarmed strain of A. tumefa 
ciens designated A208. The [3-glucuronidase gene under the 
control of the cauli?ower mosaic virus (CMV) 35S promoter 
is disclosed as being useful for the determination of trans 
formation e?iciency. 
International Patent Application WO 94/02620 discloses 
transformation of soybean using a disarmed A. tumefaciens 
designated LBA 4404 and the induction of bacterial viru 
lence by culture in media having a pH beloW 6.0. 
Kovacs and Peuppke (Mol. Gen. Genet. 242: 327—336, 
1994) discloses the genomic organiZation and restriction 
endonuclease mapping of the Ti plasmid pTiChry5. That 
publication further discloses that A. tumefaciens Chry5 is a 
highly tumorigenic strain that has the ability to transform 
soybean. 
Kovacs et al. (Mol. Gen. Genet. 242: 327—336, 1993) 
disclose that a cryptic plasmid and the bacterial chromosome 
of strain Chry5 potentiate the tumorigenic ability of several 
different Ti plasmids in comparison to their normal genetic 
background. 
Kovacs and Peuppke (Phytopathology, 81 (10): Abstract 
No. 678B, 1991) brie?y describes a plasmid-cured A. tame 
faciens derivative of Chry5 into Which the Ti plasmid of 
strain T37 Was conjugated. 
Bush and Pueppke (Appl. Environm. Micorbiol. 57(9): 
2468—2472, 1991) discusses the characteriZation ofA. tame 
faciens Chry5, isolated from naturally-occurring croWn galls 
on Chrysanthemum morifolium. Strain Chry5 is thought to 




Hood et al. (Transgenic Res. 2:208—218, 1993) discloses 
the disarming of three Ti plasmids: one each of the octopine, 
nopaline and L,L-succinamopine types. A. tumefaciens 
strains A281 and EHA101 are disclosed as able to transform 
soybean. The disarming derivative of plasmid pTiBo542 
from strain A281 is disclosed and designated pEHA105. 
Hinchee et al. (Gene Manipulation in Plant Improvement 
11, pp. 203—212, J P Gustafson, ed., Plenum Press, NeW 
York, 1990) discusses transformation of soybean by A. 
tumefaciens, Wherein out of 100 cultivars of soybean tested 
for transformation, only three Were found susceptible in 
repeated tests. Also reported is a [3-glucuronidase gene 
marker system. 
Kudirka et al. (Can. J. Genet. Cytol. 28: 808—817, 1986) 
discloses various characteristics of Wound repair in the 
presence of tumorigenic and non-tumorigenic strains of A. 
tumefaciens and that soybean explants had recently been 
transformed. 
From these prior disclosures, it is readily apparent that the 
art Would signi?cantly advance With the addition of novel 
strains of disarmed A. tumefaciens having a Wide host-range 
and the ability to more ef?ciently transform plants, such as 
soybean, that have here-to-date been refractory to 
Agrobacterium-mediated transformation. Moreover, since 
A. tumefaciens strains vary someWhat in their host range, 
creating neW disarmed strains is expected to expand the list 
of A. tumefaciens-transformable plant species. 
It is thus one object of the invention to provide novel 
disarmed A. tumefaciens strains that are ef?cient in the 
transformation of economically important crops, in particu 
lar soybean. Another object of the invention is to provide 
novel methods for increasing the ef?ciency of A. 
tumefaciens-mediated gene transfer, again particularly With 
respect to soybean. In conjunction With the foregoing, it is 
another object of the invention to provide novel genetically 
engineered Ti plasmids useful in the transformation of both 
dicots and monocots. Yet another object of the invention is 
to provide novel methods for the transformation of plants, 
particularly soybean. A further object of the invention is to 
provide transgenic plants possessing one or more genetically 
engineered desirable characteristics. These and other objects 
of the invention, apparent from the disclosure herein, are 
realiZed in the A. tumefaciens strains, exempli?ed by strain 
KYRT1, under the practice of the invention. 
SUMMARY OF THE INVENTION 
The invention provides for disarmed strains of A. tame 
faciens. The invention further provides for disarmed A. 
tumefaciens derived from strain Chry5, Wherein the plasmid 
pTiChry5 has a disarming mutation, such as deletion in part 
or all of the T-DNA. The invention also provides for a 
disarmed A. tumefaciens designated KYRT1, and deriva 
tives thereof, Which is particularly tumorigenic in dicots 
including, for example, soybean, tomato and collard. The 
invention additionally provides methods for the ef?cient 
transformation of plants, and in particular soybean. The 
invention also provides for transgenic plants transformed via 
A. tumefaciens KYRT1 or derivatives thereof. 
The invention is exempli?ed by A. tumefaciens strain 
KYRT1, Which is an avirulent version of A. tumefaciens 
Chry5, a highly tumorigenic strain on soybean. Disarming is 
accomplished by removing an approximately 18-kb BamHI 
fragment of the 285-kb plasmid pTichry5, including 
approximately 3 to 4-kb of the oncogenic T-DNA and the 
right border. The deletion is accomplished by ?rst removing 













24-kb cloned fragment of pTiChry5 in cosmid pLAF R1, and 
replacing it With a gene conferring antibiotic (carbenicillin) 
resistance. The resulting construct is introduced into A. 
tumefaciens Chry5 by bacterial conjugation and a homolo 
gous recombinant betWeen the construct and pTiChry5 is 
selected for by the subsequent conjugation of the incompat 
ible group P plasmid pPH1JI. The resulting recombinantA. 
tumefaciens strain Was named KYRT1. The transformation 
ef?ciency of KYRT1 and comparative examples (including 
EHA105) is assayed by inoculating soybean (cv. Fayette) 
cotyledonary node explants. On average, KYRT1 produced 
many more transformed multicellular sectors than the com 
parative strains, demonstrating that KYRT1 is equally or 
more effective than the comparative strains (EHA105 and 
GV3850) at delivering DNA into soybean in a binary vector 
system. 
BRIEF DESCRIPTION OF DRAWINGS 
FIGS. 1A—1C: Construction of PCH1B, triparental mat 
ing. (A) depicts an EcoRI map of pTiChry5 subclone pCH77 
shoWing the approximate locations of the oncogenic T-DNA 
(black bar) and the right border sequence (hatched bar) 
(Kovacs and Peuppke, Mol. Gen. Genet. 242: 327—336, 
1994). (B) depicts a map of pCH1B, containing the 
[3-lactamase insert from pBSL167 (Alexeyev, M. F, et al., 
Gene 160(1): 63—67, 1995), With restriction sites for EcoRI 
(E) and BamHI (B) marked. (C) presents a summary of the 
tWo triparental mating steps to disarm Chry5, resulting in 
homologous recombination betWeen pCH12 and pTiChry5. 
The detailed insert of pTiChry5 shoWs the relative positions 
of overlapping subclones pCH23 and pCH77, and the onco 
genic T-DNA. BamHI sites and fragment numbers are also 
indicated. 
FIGS. 2A—2B: Southern Analysis of total DNA of Chry5, 
Chry51B and KYRT, With probes of pTiChry5 T-DNA 
region. Total DNA of Chry5, Chry51B and KYRT, and 
cosmid DNA of pCH77 and PCH1B, Were digested With 
EcoRI and the fragments Were separated by agarose (0.8% 
TAE) electrophoresis (10 ng/lane genomic DNA, approxi 
mately 1 ng/lane pCH77 DNA and 0.1 ng/lane pCH1B 
DNA). Southern hybridiZation Was conducted at 65° C. 
using labelled probes of (A) subcloned pTiChry5 EcoRI 
fragment 11 and (B) subcloned EcoRI fragment 9. Lanes are: 
(1) cosmid clone pCH77, (2) intermediate construct pCH1B, 
and total DNA of (3) Wild-type Chry5, (4) Chry51B, and (5) 
KYRT. ArroW indicates the position of the chromosomal 
fragment homologous to pTiChry5 EcoRI fragment 11. 
DETAILED DESCRIPTION OF THE 
INVENTION 
Soybean is difficult to transform by engineered (i.e., 
disarmed) A. tumefaciens-mediated gene transfer. 
Nevertheless, A. tumefaciens is the preferred system for 
gene transfer since, With a susceptible host plant, it inte 
grates foreign DNA into the host genome With high ef? 
ciency and Without the degree of rearrangement or trunca 
tion that typically occurs With direct DNA transfer methods, 
such as particle bombardment and electroporation. 
Therefore, a disarmed version of any strain that shoWs a 
strong capacity for virulence on soybean represents a Wel 
come breakthrough in the ?eld of soybean genetic engineer 
ing. 
The invention thus provides for A. tumefaciens strain 
KYRT1 to ful?ll the need in the art and the objectives set 
forth above. A. tumefaciens KYRT1 is a disarmed derivative 
of the broad host range vector A. tumefaciens Chry5, Which 
itself is highly tumorigenic on soybean. 
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Disarming of A. tumefaciens strain Chry5 Was accom 
plished by removing approximately 18-kb of the bacterium’s 
tumor-inducing (Ti) plasmid (pTiChry5), Which included 
6-kb of the oncogenic sequences comprising the transfer 
DNA (T-DNA), Which during infection is mobiliZed into the 
plant cell by the bacteria to generate the croWn gall symp 
toms. The deleted sequences also include a short signal 
sequence called a border, Which is essential for the mobili 
Zation of the T-DNA. The deletion Was accomplished by ?rst 
removing the corresponding 18-kb region by BamHI endo 
nucleolytic digestion of plasmid pCH77, Which itself com 
prises a 24-kb fragment of the Ti plasmid (pTiChry5) of A. 
tumefaciens strain Chry5 cloned in the broad host-range 
vector pLAFR1 (Friedman et al., Gene 18: 289—296, 1982) 
(FIG. 1A). The deleted fragment Was replaced With a marker 
gene, the [3-lactamase gene, Which confers resistance to the 
antibiotic carbenicillin (FIG. 1B). The resulting construct, 
designated pCH1B, thus contained the [3-lactamase gene 
?anked on each side by approximately 4-kb of Ti plasmid 
sequence. 
Cosmid pCH1B Was then introduced into A. tumefaciens 
strain Chry5 by bacterial conjugation generating Chry51B 
(see beloW). Homologous recombination betWeen pCH1B 
and pTiChry5 Was forced by the introduction of plasmid 
pPH1JI (Hirsch and Berenger, Plasmid 12: 139—141, 1984), 
Which is incompatible With plasmid pLAFR1. The 
recombinant, KYRT1, Was identi?ed by resistance to 
carbenicillin, rifampicin (the selection marker for A. tume 
faciens strain Chry5), and gentamicin, a selection marker for 
pPH1JI (FIG. 2). Bacteria surviving this selection are 
expected to have the [3-lactamase gene integrated by 
homologous recombination into pTiChry5 in place of the 
deleted 18-kb T-DNA sequence, contain the free-living 
pPH1JI, and to have lost pCH1B in the free-living cosmid 
pLAFR1, Which rendered the strain tetracycline-sensitive. 
Southern analysis Was performed con?rming the results of 
the selection procedure, in Which the genomic and Ti plas 
mid DNA of A. tumefaciens KYRT1 rendered the expected 
results. The loss of the ability of the selected product to form 
tumors on tomato and tobacco stems, compared With the 
Chry5 Wild-type progenitor (Table 1), further con?rmed that 
the 18-kb of T-DNA had been deleted from A. tumefaciens 
Chry5. 
The use of strain KYRT1 With binary vectors having an 
RK2 origin of replication is not hindered by the presence of 
pPH1J I, Which Would be expelled by the introduction of, and 
selection for, that binary vector. This Was demonstrated by 
introducing a binary vector (pBI121) containing an intron 
containing [3-glucuronidase (GUS-INT) into A. tumefaciens 
KYRT1. The binary vector conferred kanamycin-resistance 
to the resulting strain. This strain Was also gentamicin 
sensitive due to the loss of pPH1JI. Tobacco leaf pieces 
inoculated With KYRTlzzGUS-INT produced GUS 
transformed calli on culture medium containing hormones 
and kanamycin. These calli formed shoots, Which Were 
groWn into normal rooted plants. Importantly, leaf pieces 
inoculated With KYRTlzzGUS-INT formed no callus When 
cultured on hormone-free medium, implying that the 
T-DNA, Which contains genes for phytohormone synthesis 
in infected tissue, had been effectively rendered non 
functional in KYRT1. Conversely, tissue inoculated With 
Wild-type Chry5::GUS-INT generated callus on both 
hormone-containing and hormone-free media, Which assay 
ing positive for expression of the GUS-INT gene. 
It Will be appreciated that While the preferred plant 
species for transformation is soybean (Glycine max), other 








Medicago, Lycopersicon, Brassica, Cucumis, Solanum, 
Juglans, Gossypium, Malus, Vitis, Antirrhinum, Populus, 
Fragaria, Arabidopsis, Picea, Capsicum, Chenopodium, 
Dendranthema, Pharbitis, Pinus, Pisum, OryZa, Glycine, 
Pseudotsuga, Vinis, Kaleanchoe, Beta, Helianthus and Nic 
otiana. Conifers are also preferred. 
The invention as described herein is exempli?ed by the 
deletion of T-DNA sequences betWeen tWo BamHI restric 
tion sites in order to disarm the bacterium. HoWever, it Will 
be appreciated that other disarming mutations of Wide 
host-range, highly tumorigenic Ti plasmids such as 
pTiChry5 may be used in the practice of the invention. 
Indeed, it is only necessary, in the case of a deletion, that 
suf?cient T-DNA and/or border DNAbe removed to provide 
the disabled phenotype. Moreover, disarming mutations 
other than deletions may be used under the practice of the 
invention, including (but not limited to), point mutations and 
insertions as Well as combinations of these mutational 
methods. 
The invention is exempli?ed beloW using the cotyledon 
and leaf regeneration system for the production of soybean 
and tobacco, respectively. HoWever, other regeneration sys 
tems knoWn in the art may be used as Well. These include the 
cotyledonary node, immature embryo and protoplast regen 
eration systems as Well as others knoWn to those skilled in 
the art. 
The selection of transformed tissue is most usually 
accomplished in plant regeneration by inserting an antibiotic 
resistance gene into the transformed tissue. There is a large 
number of such antibiotics useful for this purpose including, 
for example, rifampicin, carbenicillin, chloramphenicol, 
ampicillin, gentamicin, kanamycin, tetracycline, 2(N 
Morpholine)ethanesulfonic acid (MES), hygromycin. Non 
antibiotic selective agents, such as methotrexate, may also 
be employed. 
As pertaining to A. tumefaciens KYRT1 and its deriva 
tives and obvious variants, the invention is not meant to be 
limited to soybean transformation, as these vectors are 
thought to be useful in the transformation of a Wide variety 
of dicotyledonous and/or monocotyledonous plants. 
Accordingly, While soybean is the preferred plant species, 
the practice of the methods of the invention and the claims 
appended hereto are not meant to be limited in scope or spirit 
to any particular plant species. 
The utility of the present invention is Well apparent to 
those skilled in the art, for it is Widely knoWn that soybean 
is a major food and feed source and any improvements 
therein under the practice of the invention Will serve to 
further increase the agronomic value of this plant. Moreover, 
as discussed above, due to a limited genetic diversity, the 
techniques and vectors of the invention alloW for the gen 
eration of novel plant characteristics that have heretofore not 
been possible to attain by traditional breeding methods. 
The desirable characteristics that may be imparted on 
plants, particularly soybean, under the practice of the inven 
tion include, but are not limited to, resistance to Water stress, 
resistance to heat stress, resistance to cold stress, resistance 
to one or more insect pests, resistance to pesticides, 
increased yield and increased nutritional content. 
It should also be appreciated that the A. tumefaciens and 
methods of the present invention may be used to create 
plants that act as a biofactory, producing any number of 
desirable compounds. In this regard, production of pharma 
ceutically active compositions, such as peptide hormones, 
etc., and other useful protein(s) and polypeptides, including 
mammalian and human proteins and polypeptides, may be 
produced in large quantity and at reduced cost. 
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What follows hereinafter are exemplary embodiments of 
the invention, Wherein the preparation of a novel A. 
tumefaciens, KYRT1, and its use in the generation of 
transgenic soybean is disclosed. 
METHODS 
Construction of pCH1B 
Cosmid clone pCH77 contains a 24 kb fragment of 
pTiChry5 DNA including the oncogenic T-DNA and right 
border in the pLAFR1 cosmid (Kovacs and Peuppke, Mol. 
Gen. Genet. 242: 327—336, 1994). This clone Was digested 
With BamHI and the vector sequences isolated by agarose 
gel electrophoresis. Plasmid pBSL167 (Alexeyev, M. F., et 
al., Gene 160(1): 63—67, 1995), Which contains the 
[3-lactamase gene and promoter ?anked by BamHI sites Was 
similarly digested With BamHI and the insert corresponding 
to the [3-lactamase gene Was puri?ed by agarose electro 
phoresis. The gel-isolated fragments Were ligated and used 
to transform E. coli DHSO. and recombinants selected in the 
presence of tetracycline (10 pig/ml) and ampicillin (100 
pig/ml). The resulting construct, designated pCH1B, Was 
veri?ed by restriction enZyme analysis. 
Marker Exchange/Forced Recombination 
Cosmid pCH1B Was transferred into A. tumefaciens 
Chry5 using the triparental mating scheme With plasmid 
pRK2013 as the helper plasmid (Ditta et al., Proc. Natl. 
Acad. Sci. (USA), 77: 7347—7351, 1980). Transformed 
bacterium Were selected in the presence of rifampicin (100 
pig/ml) and carbenicillin (100 pig/ml). The resulting strain, 
designated Chry51B, is also tetracycline resistant. This 
strain presumably contains both pCH1B and intact 
pTiChry5. The incompatible plasmid pPH1JI (Hirsch and 
Berenger, Plasmid 12: 139—141, 1984), containing the IncP 
RK2 ori, Was next transferred into Chry51B and recombi 
nants identi?ed by simultaneous selection on LB agar con 
taining rifampicin (100 pig/ml), carbenicillin (100 pig/ml) 
and gentamicin (40 pig/ml), the latter being the selection 
marker for pPH1JI. This selection provided clones that had 
undergone the intended double recombination event. The 
sensitivity of certain of the resultant clones to tetracycline 
(10 pig/ml) Was tested, to verify that the pLAFR1 cosmid 
sequences had been lost in the recombination event. A clone 
that is resistant to gentamicin, carbenicillin and rifampicin, 
but sensitive to tetracycline Was selected and designated A. 
tumefaciens KYRT1. The identity of the recombinant is 
further veri?ed by Southern analysis of the Ti plasmid. 
Stem and Leaf Inoculations 
To test KYRT1 for loss of tumorigenicity, tobacco and 
tomato plants Were inoculated With A. tumefaciens KYRT1 
and Chry5 (see beloW). Disarmed A. tumefaciens strain 
EHA105 (Hood et al., J. Bacteriol. 168(3): 1283—1290, 
1986) and its Wild-type progenitor A281, Were used as 
controls. Five Weeks after the inoculation, large tumors of 
comparable siZe had formed on 100% of the inoculation 
sites for A. tumefaciens Chry5 and A281. In contrast, no 
tumors formed on the inoculation sites for A. tumefaciens 
KYRT1 and EHA105. One tobacco plant inoculated With 
KYRT1 did, hoWever, shoW a small amount of blister, Which 
may have been due to environmental contamination or by a 
non-agrobacterial callus formation. These results, then, indi 
cate that the homologous recombination event in A. tume 
faciens KYRT1 effectively removed the capacity for tumor 
formation in that bacterium. 
To further con?rm the loss of tumorigenicity in A. tume 
faciens strain KYRT1, a GUS-INT construct Was used for 
the transformation of tobacco leaves via Chry5, KYRT1 and 
EH105. As expected, tumorigenic strain Chry5::GUS-INT 













medium containing the hormones cytokinin (BAP) and 
auxin (IAA), strain KYRT1::GUS-INT and EHA105::GUS 
INT formed calli at the inoculation sites, Whereas there Was 
no callus formation in the absence of these hormones. 
Moreover, calli and plantlets from calli inoculated With 
KYRT1::GUS-INT Were positive for GUS as indicated by 
histochemical staining. These results indicate that A. tume 
faciens KYRT1 has maintained a functional vir region, and 
can transfer foreign T-DNA containing heterologous genes, 
from introduced binary vectors. 
Stem Inoculation Assay 
Stems from tWo-month old tobacco (cv. Ky14) and three 
Week old tomato (cv. “Big Boy”) Were inoculated With 
Wild-type A. tumefaciens Chry5, KYRT1, A281 and 
EHA105 (Which is a disarmed strain A281 as an avirulent 
control). TWo day old cultures Were suspended to a density 
of ca. 108 cells/ml in phosphate buffered saline (PBS) , and 
applied With a 3 cm3 syringe through a 17-gauge needle. The 
loWer leaves of the tobacco plant Were removed and the 
exposed regions Were inoculated in tWo internodes, on 
opposite sides of the stem. The stem Was scratched With a 
needle, making a ca. 3 mm Wound, and the bacterial sus 
pension Was applied as a droplet to the freshly-made Wound. 
Tomato plants are inoculated by piercing the stem With the 
needle, at tWo internodes, and applying a droplet of bacterial 
suspension at each of the Wound openings. Plants Were 
maintained under greenhouse conditions and fertiliZed 
Weekly With a N-P-K (20:20:20) fertiliZer. Tumor formation 
Was scored by calculating the siZe of the tumor surface 5 
Weeks after inoculation. 
Tobacco Leaf Transformation 
Abinary plasmid Was conjugated into Chry5, KYRT1 and 
EHA105 by triparental mating as discussed above. The 
Km-resistant plasmid contains the GUS-intron gene in 
pBl121 (Clonetech, Inc.). Strains containing the binary 
plasmid Were selected by resistance to kanamycin (100 
pig/ml). The A. tumefaciens strains Were used to inoculate 
excised leaves of aseptically groWn, one month old tobacco 
(cv. Ky160) seedlings. TWo day bacterial cultures in 5 ml LB 
medium containing rifampicin (100 pig/ml) and kanamycin 
(100 pig/ml) Were tWice centrifuged and resuspended in 5 ml 
LB Without antibiotics. Tobacco leaves are dipped into the 
bacterial suspension and either halved or quartered. Leaf 
sections are transferred to modi?ed Murashige and Skoog 
medium containing 3% sucrose and the hormones indoleace 
tic acid (1 mg/L) and benZyladenine (10 pM). After three 
days incubation, the leaf sections are Washed in sterile Water, 
blotted dry on sterile paper toWels and transferred either to 
TOM medium (containing hormones) or T-medium (TOM 
medium lacking hormones), containing mefoxin (500 mg/L) 
and kanamycin (300 mg/L). Leaf explants Were transferred 
to fresh medium after an additional three days and thereafter 
every seven days. 
Soybean Cotyledonary Node Explant Assays 
Soybean seedling cotyledonary node explants Were inocu 
lated With KYRT::GUS-INT as a test for stable transforma 
tion of soybean. Disarmed A. tumefaciens strains GV3850 
and EHA105, also containing GUS-INT Were also assayed 
for comparative purposes. On average, explants inoculated 
With KYRT1::GUS-INT produced three times as many 
GUS-positive sectors (as judged by histochemical staining) 
as explants inoculated With either GV3850::GUS-INT or 
EHA105::GUS-INT. Based upon chi-square analysis, the 
difference betWeen KYRT1 and GV3850 Was signi?cant at 
the 0.01 level, While that betWeen KYRT1 and EHA105 Was 
signi?cant at the 0.05 level. These results demonstrate the 
clear improvement in transformation ef?ciency using A. 
tumefaciens strain KYRT1. 
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Soybean Cotyledonary Nodes 
Cotyledonary node cultures Were initiated from 3 day-old 
seedlings of soybean (cv. Fayette) (Townsend, J. A., Inter 
national Patent Application No. WO 94/02620, 1994). A. 
tumefaciens strains KYRT1, EHA105 and GV3850 contain 
ing GUS-INT Were groWn as 1 ml cultures for tWo days in 
LB medium containing rifampicin (100 pig/ml) and kana 
mycin (100 pig/ml). A. tumefaciens GV3850 and KYRT1 
growth medium also contains carbenicillin (100 pig/ml). 
These tWo-day cultures are used to inoculate 100 ml 
cultures, Which are then groWn overnight to mid-log phase. 
Cultures Were pelleted and resuspended as tWo 10 ml 
aliquots in co-cultivation medium (Gamborg B5 medium 
containing 44 pM benZyladenine, 0.5 pM indolebutyric acid 
and buffered to pH 5.5 With 10 mM MES) containing 
acetosytingone (100pM). Three day-old seedlings Were pre 
pared (Veluthambi et al., J. Bacteriol. 170(4): 1523—1532, 
1988; ToWnsend, International Patent Application No. WO 
94/02620, 1994), and immersed in the bacterial suspension 
for one hour. EXplants are cultured adaXial side up on 
solidi?ed co-cultivation medium for three days, after Which 
they are Washed With sterile Water, blotted dry and cultured 
adaXial side doWn on counter-selection medium (Gamborg 
B5 containing benZyladenine (5 pM), indolebutyric acid (0.5 
pM) and buffered to pH 5.7 With 3 mM MES), containing 
mefoXin (500 mg/L) and vancomycin (200 mg/L). After one 
Week, the eXplants are transferred to counter-selection 
medium containing mefoXin (250 mg/L), vancomycin (100 
mg/L) and kanamycin (100 mg/L) and sub-cultured every 
tWo to three Weeks thereafter. SiX Weeks after inoculation, 
shoot masses that form at the base of the cotyledon are 
harvested, cut into ca. 1.5 mm thick sections and assayed for 
GUS activity by histochemical staining (Jefferson, Plant 
Mol. Biol. Rep. 5: 387—405, 1987). On average, eXplants 
inoculated With KYRTlzzGUS-INT produced three times as 
many GUS-positive sectors as eXplants inoculated With 
either GV3850zzGUS-INT or EHA105::GUS-INT. The dif 
ference betWeen KYRT1 and GV3850 Was signi?cant to the 
0.1 level based on chi-square analysis Whereas the difference 
betWeen KYRT1 and EHA105 Was signi?cant at the 0.05 









disarmed vector for the transformation of soybean cotyle 
donary node tissue. 
The above-embodiments of the invention are meant to be 
illustrative and are not to be construed as limiting on the 
broad claims appended hereto. Obvious variants of the 
embodiments disclosed are readily recogniZed by those 
skilled in the art and are meant to be Within the scope and 
spirit of the claims. 
Each of the publications and patents cited herein are 
expressly incorporated herein by reference thereto. 
We claim: 
1. A disarmed A grobacterium tumefaciens strain KYRT1, 
having ATCC Accession No. 202167. 
2. A method of producing a transgenic plant comprising 
the steps: 
(a) introducing a binary vector comprising a gene of 
interest into the disarmed Agrobacterium tumefaciens 
strain of claim 1 to produce a recombinant A. tumefa 
ciens; 
(b) contacting said recombinantA. tumefaciens of With at 
least one site on a plant tissue, Wherein said site 
comprises a Wound site, and said plant tissue is selected 
from the group consisting of embryogenic, cotyledon 
ous and somatic tissue; and 
(c) culturing said plant tissue to alloW regeneration of said 
tissue into a transgenic plant. 
3. The method of producing a transgenic plant according 
to claim 2, Wherein said plant tissue is a dicotyledonous 
plant tissue. 
4. The method of producing a transgenic plant according 
to claim 3, Wherein said dicoytyledonous plant tissue is 
soybean (Glycine max) plant tissue. 
5. The method of producing a transgenic plant according 
to claim 3, Wherein said dicotyledonous plant tissue is from 
a conifer or from a genus selected from the group consisting 
of Medicago, Lycopersicon, Brassica, Cucumis, Solanum, 
Juglans, Gossypium, Malus, Vitis, Antirrhinum, Populus, 
Fragaria, Arabidopsis, Picea, Capsicum, Chenopodium, 
Dendranthema, Pharbitis, Pinus, Pisum, OryZa, Glycine, 
Pseudotsuga, Kalanchoe, Beta, Helianthus and Nicotiana. 
* * * * * 
